- Home
- FBRX vs ONTF Comparison
FBRX vs ONTF Comparison
Compare FBRX & ONTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FBRX | ONTF |
|---|---|---|
| Founded | N/A | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 379.3M | 347.2M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FBRX | ONTF |
|---|---|---|
| Price | $24.09 | $8.11 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $67.00 | $8.10 |
| AVG Volume (30 Days) | 196.5K | ★ 599.1K |
| Earning Date | 03-31-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.30 | 32.67 |
| EPS | N/A | ★ N/A |
| Revenue | $36,000.00 | ★ $139,312,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.91 | $4.35 |
| 52 Week High | $35.62 | $8.11 |
Technical Indicators
Market Signals| Indicator | FBRX | ONTF |
|---|---|---|
| Relative Strength Index (RSI) | 38.79 | 67.87 |
| Support Level | $21.94 | $7.84 |
| Resistance Level | $32.40 | N/A |
| Average True Range (ATR) | 2.65 | 0.02 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 26.15 | 88.89 |
Price Performance
Historical ComparisonAbout FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
About ONTF ON24 Inc.
ON24 Inc provides a cloud-based intelligent engagement platform that combines experiences with personalization and content, to enable sales and marketing organizations to capture and act on connected insights at scale. The company's platform offers a portfolio of interactive and hyper-personalized digital experience products that create and capture actionable, real-time data at scale from millions of professionals to provide businesses with buying signals and behavioral insights to efficiently convert prospects into customers. It provides solutions to Financial services, Life Sciences, Life sciences, Insurance, Technology, Associations, and Others. Geographically, the company derives maximum revenue from United States, and also has its presence in EMEA and Other Countries.